Search Results for “NHS” – Page 19 – media

NICE sticks with ‘no’ for earlier use of Halaven

Cost regulators for NHS treatments in England and Wales are sticking with their position that Eisai’s Halaven should not be funded by the NHS as a second-line of attack against a certain form of breast cancer.
- Source: pharmatimes
- 1,831
- February 23, 2018
breast cancer Market Views NHS
Surgeons use Microsoft HoloLens to ‘see inside’ patients before they operate on them

Surgeons in the UK are using Microsoft’s mixed-reality headset to “see inside” patients before they operate on them.
- Source: Microsoft
- 753
- February 9, 2018
healthcare technologies and innovations medical device Microsoft Researches
DeepMind Diagnoses Eye Disease With Artificial Intelligence

Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.
- Source: Frontline Genomics
- 545
- February 9, 2018
AI digital health Researches
Medial EarlySign’s AI scans medical records for diabetes warning signs

A machine learning technology developed to spot dangerous medical conditions before they worsen has shown its value in a trial.
- Source: PharmaPhorum
- 584
- February 7, 2018
AI diabetes NHS Researches
Augmented Reality Helps Surgeons ‘See Through’ Tissue & Reconnect Blood Vessels

Surgeons use Microsoft HoloLens headsets while operating on patients undergoing reconstructive lower limb surgery.
- Source: ODT
- 582
- February 2, 2018
augmented reality medical device Researches surgery
NICE becomes latest champion for digital health

NICE has become the latest organisation to champion digital health, recommending that the NHS should trial an online and mobile programme to treat depression.
- Source: Pharma Phorum
- 745
- February 1, 2018
Company Insight digital health EHR NICE
Blood cancer care needs improving, finds MP inquiry

The Government’s 2015 Cancer Strategy is failing to support blood cancer patients in the UK and care must improve, an MP inquiry has found.
- Source: pharmatimes
- 649
- January 19, 2018
blood cancer NHS polices
Unforeseen new drug target discovered for acute myeloid leukemia

A study has found an unexpected new drug target for acute myeloid leukaemia (AML) that could open new avenues to develop effective treatments against this potentially lethal disease. Researchers from the Wellcome Trust Sanger Institute, the Gurdon Institute and their collaborators show that inhibiting the METTL3 gene destroys human and mouse AML cells without harming non-leukaemic blood cells.
- Source: medicalxpress
- 574
- November 28, 2017
AML blood cancer Chemotherapy leukaemia Researches
Merck, Pfizer launch Bavencio for rare skin cancer

Merck and Pfizer have launched in the UK of Bavencio, the first medicine to be licensed for the treatment of the rare, aggressive skin cancer of metastatic Merkel Cell Carcinoma (mMCC).
- Source: Pharmatimes
- 488
- November 7, 2017
avelumab Company Insight mMCC skin cancer
The fight against obesity–To tax or not to tax?

The debate explores whether food taxation is an indispensable strategy to correct obesity trends, or whether there should be other ways of approaching the problem.
- Source: Medicalxpress
- 500
- November 6, 2017
food taxation obesity

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.